🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free

    Sable Bio

    The company provides an AI-powered platform called Sable Target Intelligence designed for toxicologists in the biotech and pharmaceutical industries. The software unifies safety data from clinical, genetic, experimental, and literature sources to help teams prioritize and mitigate toxicology risks. It enables users to evaluate drug target safety systematically, replacing static reports with up-to-date data to reduce bottlenecks in the assessment process.

    Visit websiteLondon, UK
    Software
    Healthcare
    Biotechnology
    Artificial Intelligence

    Funding summary

    Total raised
    €4.9M
    Funding rounds
    2

    Investors in Sable Bio

    Investors on record for Sable Bio. Click any investor to view their CAPLINK profile and funding criteria.

    Fundraising for a startup like Sable Bio?

    Explore CAPLINK's investor database of thousands of active VCs and angels.

    Browse investors

    We use cookies to enhance your experience. Read our Privacy Policy